Live feed
·
INSIDERFilingvia Quantisnow
Checkpoint Therapeutics Inc. logo

Director Amit Sharma was granted 12,195 shares, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CKPT (Checkpoint Therapeutics Inc.) and more on Quantisnow.